Truveris

New York, United States

Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.

$15.0M raised

May 2024

Series E

Top Investors

First Round CapitalTribeca Venture PartnersPROOFCanaan PartnersNew Leaf Venture Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Truveris raised?

Truveris has raised $15.0M in total funding. The most recent round was Series E. The last funding was announced in May 2024.

Who are Truveris's investors?

Truveris's investors include First Round Capital, Tribeca Venture Partners, PROOF, Canaan Partners, New Leaf Venture Partners.

Where is Truveris headquartered?

Truveris is headquartered in New York, United States.

What does Truveris do?

Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.

What stage is Truveris at?

Truveris is at the Series E stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 14, 2024.

MLA

"Truveris — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/truveris. Accessed June 4, 2026.

APA

VCBacked. (2024). Truveris — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/truveris

Wikipedia (cite web)

{{cite web |title=Truveris — Funding & Investors |url=https://www.vcbacked.co/company/truveris |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 14, 2024.